The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan.
Kouji OkadaKensuke UsuiDaisuke KikuchiMasanori TakahashiYoshiteru WatanabePublished in: Clinical and experimental nephrology (2020)